AI could help speed up drug discovery and cut animal testing
In short: A review of pharmaceutical research describes how artificial intelligence and machine learning could speed up drug discovery by scanning genomic and protein data to flag disease-related targets and predict how candidate drugs might interact with them. The authors also describe how these computational tools could help predict a drug's toxicity and behaviour in the body, potentially reducing reliance on animal testing.
The review surveys many proposed AI applications across drug discovery, dosage-form design, manufacturing and pharmacokinetics, rather than testing any single method against real-world outcomes. Because it summarises existing proposals and notes drawbacks without quantifying them, how much these tools actually improve drug development in practice remains to be shown.
Why it matters: AI tools show promise for making drug development faster and more targeted, but this remains an early, unproven application area.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Source: Research: Vora et al. (2023). Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design. Pharmaceutics. · cc-by
To cite this card, link to https://intellectplus.co.uk/app/technology-research-artificial-intelligence-offers-new-ways-to-optimize-drug-dis.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?